New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 2, 2013
12:39 EDTSGYPSynergy Pharmaceuticals price target raised to $13 from $7 at Cantor
Cantor increased its target on Synergy after the company reported results from a Phase III trial of its chronic constipation treatment, plecanatide, that the firm views as positive. The firm increased its E.U. and Japanese sales estimates for the drug, and it sees the company as a takeover target. Cantor believes that Synergy has multiple upcoming positive catalysts and it maintains a Buy rating.
News For SGYP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 2, 2015
17:18 EDTSGYPSynergy Pharmaceuticals files $250M mixed securities shelf
Subscribe for More Information
June 24, 2015
05:59 EDTSGYPStocks with implied volatility below IV index mean; SGYP WMB
Subscribe for More Information
June 23, 2015
10:30 EDTSGYPOptions with decreasing implied volatility
Subscribe for More Information
09:14 EDTSGYPOn The Fly: Pre-market Movers
Subscribe for More Information
06:36 EDTSGYPSynergy Pharmaceuticals volatility elevated
Subscribe for More Information
06:02 EDTSGYPSynergy Pharma begins second of two Phase 3 clinical trials of plecanatide
Synergy Pharmaceuticals announced the initiation of the second of two pivotal phase 3 clinical trials evaluating the efficacy and safety of two different plecanatide treatment doses, taken as a tablet once-a-day, in patients with irritable bowel syndrome with constipation, or IBS-C. The phase 3 IBS-C program includes two randomized, 12-week, double-blind, placebo-controlled pivotal trials conducted in the U.S. and each trial is expected to enroll approximately 1050 adult patients with IBS-C.
June 22, 2015
15:41 EDTSGYPSynergy Pharmaceuticals volatility elevated on sharp rally
Synergy Pharmaceuticals July is at 134, October is at 95; compared to its 52-week range of 72 to 158; suggesting large near term price move movement.
10:21 EDTSGYPOptions with decreasing implied volatility
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use